AJMC® in the Press, November 10, 2017

Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, but did not recommend discontinuation of any of the drugs studied.

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

A meta-analysis finds no significant increase in suicide-related events with glucagon-like peptide-1 receptor agonists.

The extension of the emergency declaration, originally set to expire on March 21, continues to allocate funding to addressing the opioid crisis.